Current treatment of advanced prostate cancer is hormonal manipulation .[ ix] A However, the effects of this treatment lasts is generally between 24 and 36 months, at which time patients may become refractory to hormone therapy and as a candidates for chemotherapy,[x] A as Taxotere. Of the year Taxotere.
[v] ‘SWOG 9916: A randomized phase III trial of docetaxel / estramustine versus mitoxantrone / prednisone in men with androgen – posted ‘as to the American Society of Clinical Oncology website.‘the timing of the congestive heart failure therapy is gradually, comprising in uptitration medication, revaluation of the patient symptoms and signs of, clinician firmness and patience, and BNP levels receive It not have easy answers and no easy fixes in the search. For one biomarkers of diagnostics, prognosis and therapy of heart failure. Whereas COBA can be a useful instrument for guiding therapeutic, it is acceptable , the method of reducing the BNP levels, which. Most relevant for improve outcomes for patients with heart failure ‘.. JAMA 301[ 4]:383-392 Click here for See abstract onlineEditorial:. BNP – Guided Therapy on cardiac insufficiency – and Ileana L. From Case Western Reserve University Louis Stokes VA Medical Center, hotels in Cleveland, and Christopher O’Connor, post of Duke University, to an accompanying editorial that there may his a few usefulness BNP as a biomarker of heart failure.
Cardiac insufficiency therapy through BNP out better outcomes in patients aged sixty to seventy-five years but not in those 75 years and older. ‘The results TIME – CHF study suggest that persistence in enhancing medicinal therapy seems to be key for an optimal clinical outcomes of patients aged 60 to 74, while it may not be beneficial push dose to the limits at patients aged 75 years or older, ‘the authors write. ‘Together the main results to the TIME – CHF study the study stresses need for new studies using special at the large population of elderly patient cardiac failure failure ‘.